Sierra Capital LLC Amgen Inc Transaction History

Sierra Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $117,841 - $132,903	-525 Reduced 95.45%	25 $6,000
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 1.79%	550 $134,000
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $25,873 - $28,623	-118 Reduced 17.4%	560 $135,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $8,949 - $10,242	45 Added 7.11%	678 $153,000
Q1 2021 May 28, 2021	BUY	$221.91 - $258.6 $140,469 - $163,693	633 New	633 $157,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sierra Capital LLC with notifications on news.